In addition to lowering blood glucose, GLP-1RAs can increase feelings of fullness, promote weight loss, and have potential benefits in cardiovascular protection
On day 0, iPSC colonies were harvested using Accutase (Merck) to obtain a single-cell suspension
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, compared to semaglutide (GLP-1 only) and tirzepatide (GLP-1 and GIP)
As a result, it can play a vital role in weight management, as it helps the body more efficiently metabolize fat
As the popularity of these drugs grows, it's likely we'll see further adaptations and innovations across various consumer sectors, all influenced by the profound impact of these powerful medications on daily life and health.